MORGAN EQUITIES GROUP, INC. Filed by LOEVNER ROBERT B.

Similar documents
GLOBUS MEDICAL INC Filed by PAUL DAVID C

GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

Pharma-Bio Serv, Inc.

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC

24889/1 07/19/ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D Under the Securities Exchange Act of

NEWS CORP Filed by SAUD H R H PRINCE ALWALEED BIN TALAL BIN ABDULAZIZ AL

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

Spark Therapeutics, Inc.

XILINX INC Filed by VANGUARD GROUP INC

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

COMCAST CORP Filed by MICROSOFT CORP

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

GENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

DIAMOND RESORTS INTERNATIONAL, INC. Filed by GUGGENHEIM CAPITAL LLC

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

HAWK SYSTEMS, INC. Filed by GREYSTONE BUSINESS CREDIT II, L.L.C.

EXFO INC. FORM SC 13G/A. (Amended Statement of Ownership) Filed 01/19/12

NEVADA GOLD & CASINOS INC Filed by HABERKORN STEPHEN J

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

GROUPON, INC. Filed by KEYWELL BRADLEY A

STRAIGHT PATH COMMUNICATIONS INC. Filed by MILLER LLOYD I III

INTERNATIONAL WIRE GROUP INC Filed by BLACKSTONE DISTRESSED SECURITIES ADVISORS LP

HASBRO INC Filed by CAPITAL GROUP COMPANIES INC

AULT INC Filed by BEL FUSE INC /NJ

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

KINGSTONE COMPANIES, INC.

OWENS CORNING Filed by OWENS CORNING/FIBREBOARD ASBESTOS PERSONAL INJURY TRUST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C BARNES & NOBLE, INC.

AMBOW EDUCATION HOLDING LTD. Filed by GIC PRIVATE LTD

National American University Holdings, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

OCI PARTNERS LP Filed by OCI N.V.

VORNADO REALTY TRUST Filed by INTERSTATE PROPERTIES

Realogy Holdings Corp.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

FORBES ENERGY SERVICES LTD. Filed by WEST FACE CAPITAL INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

VOXELJET AG Filed by TECHNOLOGIE BETEILIGUNGSFONDS BAYERN GMBH & CO. KG

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

THERAVANCE INC Filed by BAUPOST GROUP LLC/MA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Amendment No. 1) Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

3M CO Filed by BLACKROCK INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

FISERV INC Filed by BLACKROCK INC.

GENCO SHIPPING & TRADING LTD Filed by AURELIUS CAPITAL MANAGEMENT, LP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

STRAYER EDUCATION INC Filed by AXA FINANCIAL INC

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

SCHEDULE 13G. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Under the Securities Exchange Act of (Amendment No.

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Alliqua BioMedical, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

BAIN CAPITAL SPECIALTY FINANCE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Signet Jewelers (Name of Issuer)

UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

MOODYS CORP /DE/ Filed by CHILDRENS INVESTMENT FUND MANAGEMENT (UK) LLP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934

Sapiens International Corporation N.V. (Name of Issuer)

Section 1: SC 13G/A (SC 13G/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

Silvercrest Asset Management Group Inc. (Name of Issuer)

ACCESS INTEGRATED TECHNOLOGIES INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

ARIAD PHARMACEUTICALS INC Filed by SARISSA CAPITAL MANAGEMENT LP

Enzymotec Ltd. (Name of Issuer)

Tallgrass Energy Partners, LP (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

HATTERAS CORE ALTERNATIVES FUND, L.P.

Rose Rock Midstream, L.P. (Name of Issuer)

Carvana Co. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

LEAR CORP Filed by ICAHN CARL C

Transcription:

MORGAN EQUITIES GROUP, INC. Filed by LOEVNER ROBERT B. FORM SC 13D (Statement of Beneficial Ownership) Filed 03/28/13 Address 1804 JEROME AVENUE BROOKLYN, NY, 11235 Telephone 7183323994 CIK 0001108515 SIC Code 7389 - Services-Business Services, Not Elsewhere Classified Fiscal Year 12/31 http://www.edgar-online.com Copyright 2019, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Deaf Talk Inc. (Symbol: MGQG) d/b/a DT Interpreting (Name of Issuer) Common Stock (Title of Class of Securities) 63936N106 (CUSIP Number) Kevin Maloney 110 Martinak Lane, Fayette City, Pa 724.570.4026 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 18 March 2013 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 63936N106 1. Name of Reporting Persons: Robert Loevner 2. Check the Appropriate Box If a Member of a Group a. [ ] NA b. [ ] NA 3. SEC Use Only 4. Source of Funds: PF 5. Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] NA 6. Citizenship or Place of Organization: US Citizen Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 425,000 8. Shared Voting Power NA 9. Sole Dispositive Power NA 10. Shared Dispositive Power NA 11. Aggregate Amount Beneficially Owned by Each Reporting Person 425,000 12. Check If the Aggregate Amount in Row 11 Excludes Certain Shares [ ] 13. Percent of Class Represented by Amount in Row 11 5% 14. Type of Reporting Person IN

Item 1. Security and Issuer; Securities are Common Stock of Deaf Talk, Inc. d/b/a; DT Interpreting (Symbol: MGQG) with Executive Offices located at; 14 E. Main Street Carnegie, PA 15106-2456 Item 2. Identity and Background (a) Robert Loevner (b) 7417 Lighthouse Point, Pgh, Pa 15221 (c) (d) (e) (f) NA NO NO US Citizen Item 3. Source and Amount of Funds or Other Consideration Source of Funds are personal funds. Amount of funds used up to this filing is approximately; $10,000. No funds are borrowed or otherwise obtained for the this purposed takeover/acquisition by Robert Loevner. Item 4. Purpose of Transaction; The purpose of the Transaction is to take over Deaf Talk Inc., d/b/a DT Interpreting, provide substantially greater revenue and earnings through existing clients, new clients; and joint venture partnerships with symbiotic companies of equal or greater gravitas. I intend to put forth a buy back of the Common shares that are registered as Common Shares Outstanding and trading. The buyback will be at a significant multiple to the current trading price; Current Price as of 2:08PM EST this 25 th day of March is reported at $0.04 cents per share. I intend to keep certain key management and replace the board of directors with a Board of Directors of qualified individuals, in good standing with industry and the Securities and Exchange Commission ( SEC ), as certain historical members of the board and/or afflicate of the company may not have been in good standing with the SEC. The term of each board of director will be one (1) year until voted on accordingly. In addition the number of Board of Directors will be five (5) persons. This takeover will not involve the liquidation of any of the Issuers assets or subsidiaries or sale or transfer of material assets. There will a change in the capitalization structure to create addition free cash flow for enhanced shareholder value and growth, coupled with a disclosed dividend policy contrary to what is now non-disclosed earnings for distribution or dividends. There will not be a change in the shares authorized, issued and outstanding; or, class of equities securities changed, to include, there will be no registration of restricted and/or unregistered shares allowed that may dilute or adversely impact the common shares of shareholders of record. Item 5. Interest in Securities of the Issuer (a) The aggregate number of shares identified is five (5%) percent (425,000) of the Issuers 8,368,093 (b) The person in name thereof is; Robert Loevner (c) There are no prior transactions to this security (1) The identity of the person covered by Item 5(c) who effected the transaction is Robert Loevner; (2) The date of the transaction was 18 March 2013; (3) The amount of securities involved 425,000 shares; (4) The price per share was ~ $0.035 cents per share; And (5) Where and how the transaction was effected; transaction was effected by Merrill Lynch, Pittsburgh, Pa (d) Not applicable. (e) Not applicable. Item 6. Contract, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer NONE Item 7. Materials to Be Filed as Exhibits There are no Materials or Exhibits to be filed as outlined and/or defined in the Schedule 13D

SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 3/26/2013 By: /s/ Robert B. Loevner Name: Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C, 1001)